Q1 2026 Holdings
Filed 2026-05-15 | 21 holdings | $552.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alumis Inc(ALMS) | COM | 022307102 | $70.5M | 3,202,075 | 12.8% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $60.5M | 4,349,885 | 10.9% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $60.4M | 542,696 | 10.9% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $47.9M | 824,532 | 8.7% |
| Pharvaris N V(PHVS) | COM | N69605108 | $33.9M | 1,201,402 | 6.1% |
| Immix Biopharma Inc(IMMX) | COM | 45258H106 | $33.6M | 3,693,585 | 6.1% |
| Celcuity Inc(CELC) | COM | 15102K100 | $32.2M | 281,904 | 5.8% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $30.8M | 162,961 | 5.6% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $28.8M | 449,926 | 5.2% |
| X4 Pharmaceuticals Inc(XFOR) | COM NEW | 98420X202 | $26.7M | 6,456,646 | 4.8% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $24.1M | 626,635 | 4.4% |
| Monopar Therapeutics Inc(MNPR) | COM NEW | 61023L207 | $18.9M | 345,626 | 3.4% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $17.5M | 966,609 | 3.2% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $14.2M | 10,949,084 | 2.6% |
| Candel Therapeutics Inc(CADL) | COM | 137404109 | $14.2M | 2,896,588 | 2.6% |
| Oculis Holding AG(OCS) | ORDINARY SHARES | H5870P102 | $13.7M | 516,761 | 2.5% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $9.2M | 4,166,666 | 1.7% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $6.5M | 3,863,445 | 1.2% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $4.4M | 739,960 | 0.8% |
| Alto Neuroscience Inc(ANRO) | COM SHS | 02157Q109 | $2.0M | 88,999 | 0.4% |
| Satellos Bioscience Inc(MSLE) | COM | 80401L803 | $2.0M | 350,000 | 0.4% |